A BILL 
To direct the Secretary of Veterans Affairs to conduct a 
review of the deaths of certain veterans who died by 
suicide, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Veteran Suicide Pre-
4
vention Act’’. 
5
SEC. 2. DEPARTMENT OF VETERANS AFFAIRS REVIEW OF 
6
CERTAIN VETERANS’ DEATHS BY SUICIDE. 
7
(a) REVIEW REQUIRED.—Not later than 18 months 
8
after the date of the enactment of this Act, the Secretary 
9
16:09 Mar 13, 2021
H1123
khammond on DSKJM1Z7X2PROD with BILLS
2 
•HR 1123 IH
of Veterans Affairs shall complete a review of the deaths 
1
of all covered veterans who died by suicide during the five- 
2
year period preceding the date of the enactment of this 
3
Act. Such review shall include— 
4
(1) the total number of veterans who died by 
5
suicide during the five-year period preceding the 
6
date of the enactment of this Act; 
7
(2) a summary of such veterans that includes 
8
the age, gender, and race of such veterans; 
9
(3) a comprehensive list of the medications pre-
10
scribed to, and found in the systems of, such vet-
11
erans at the time of their deaths, specifically listing 
12
any medications that carried a black box warning, 
13
were off-label, psychotropic, or carried warnings that 
14
included suicidal ideation; 
15
(4) a summary of medical diagnoses by Depart-
16
ment of Veterans Affairs physicians which led to the 
17
prescribing of the medications referred to in para-
18
graph (3); 
19
(5) the number of instances in which the vet-
20
eran who died by suicide was concurrently on mul-
21
tiple medications prescribed by Department of Vet-
22
erans Affairs physicians; 
23
16:09 Mar 13, 2021
H1123
khammond on DSKJM1Z7X2PROD with BILLS
3 
•HR 1123 IH
(6) the percentage of veterans who died by sui-
1
cide who were not taking any medication prescribed 
2
by a Department of Veterans Affairs physician; 
3
(7) the percentage of veterans referred to in 
4
paragraph (1) with combat experience or trauma 
5
(including, but not limited to military sexual trauma, 
6
traumatic brain injury, and post-traumatic stress); 
7
(8) Veteran Health Administration facilities 
8
with markedly high prescription and suicide rates of 
9
patients being treated at those facilities; 
10
(9) a description of Department of Veterans Af-
11
fairs policies governing the prescribing of medica-
12
tions referred to in paragraph (3); 
13
(10) any patterns apparent to the Secretary 
14
based on the review; and 
15
(11) recommendations for further action that 
16
would improve the safety and well-being of veterans. 
17
(b) PUBLIC AVAILABILITY.—Not later than 30 days 
18
after the completion of the review required under sub-
19
section (a), the Secretary shall— 
20
(1) submit to Congress a report on the results 
21
of the review; and 
22
(2) make such report publicly available. 
23
(c) COVERED VETERAN.—In this section: 
24
16:09 Mar 13, 2021
H1123
khammond on DSKJM1Z7X2PROD with BILLS
4 
•HR 1123 IH
(1) The term ‘‘covered veteran’’ means any vet-
1
eran who received hospital care or medical services 
2
furnished by the Department of Veterans Affairs 
3
during the five-year period preceding the death of 
4
the veteran. 
5
(2) The term ‘‘black box warning’’means a 
6
warning displayed within a box in the prescribing in-
7
formation for drugs that have special problems, par-
8
ticularly ones that may lead to death or serious in-
9
jury. 
10
Æ 
16:09 Mar 13, 2021
H1123
khammond on DSKJM1Z7X2PROD with BILLS
